eHSP90alpha in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma. Bian Y, Liu H, Huang J, Feng Z, et al. BMC Cancer 2024;24:835.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bian Y, Liu H, Huang J, Feng Z, et al. eHSP90alpha in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma. BMC Cancer 2024;24:835.
PMID: 38997622